Invention Grant
- Patent Title: Histone deacetylase inhibitors
-
Application No.: US14890331Application Date: 2014-05-12
-
Publication No.: US09862685B2Publication Date: 2018-01-09
- Inventor: Stephen J. Shuttleworth , Cyrille D. Tomassi , Alexander R. L. Cecil , Somhairle MacCormick , William J. Nodes , Franck A. Silva
- Applicant: Karus Therapeutics Limited
- Applicant Address: GB Abingdon, Oxfordshire
- Assignee: Karus Therapeutics Limited
- Current Assignee: Karus Therapeutics Limited
- Current Assignee Address: GB Abingdon, Oxfordshire
- Agency: Goodwin Procter LLP
- Priority: GB1308409.0 20130510; GB1315253.3 20130828
- International Application: PCT/GB2014/051454 WO 20140512
- International Announcement: WO2014/181137 WO 20141113
- Main IPC: A61K31/497
- IPC: A61K31/497 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D213/72 ; C07D213/74 ; C07D413/12 ; C07D417/12 ; C07D417/14 ; C07D495/04 ; C07D285/08 ; A61K45/06 ; A61K31/433 ; A61K31/4365 ; A61K31/4439 ; A61K31/444 ; A61K31/501 ; A61K31/506 ; A61K31/5377
Abstract:
The present invention is a compound of the formula or a pharmaceutically acceptable salt thereof. The compounds are useful as HDAC inhibitors.
Public/Granted literature
- US20160096804A1 NOVEL HISTONE DEACETYLASE INHIBITORS Public/Granted day:2016-04-07
Information query
IPC分类:
